Gw-1516
Generic Name: gw-1516
Dosage form: POWDER. Active ingredients: GW-501516 (1 g/g). Category: BULK INGREDIENT.
Overview
Dosage form: POWDER. Active ingredients: GW-501516 (1 g/g). Category: BULK INGREDIENT.
Dosage
Available as powder.
Related Medications
Cr-371059 Tolnaftate 1%
cr-371059 tolnaftate 1%
Purpose Antifungal
Buprenorphine
buprenorphine
Buprenorphine sublingual tablets are indicated for the treatment of opioid dependence as part of a comprehensive treatment plan including counseling and psychosocial support.
Betaine - Bufo Bufo Cutaneous Gland - Calcium Carbonate - Chromic Sulfate - Cicuta Virosa Root - Copper - Folic Acid - Gold - Cobalamin - Iron - Lachesis Muta Venom - Melatonin - Molybdenum - Neurotrophin-3 - Neurotrophin-4 - Oxytocin - Silicon Dioxide - Sus Scrofa Frontal Lobe - Sus Scrofa Temporal Lobe - Thyrotropin Alfa - Ubidecarenone - Vanadium - Zinc - Brain-derived Neurotrophic Factor Human -
betaine - bufo bufo cutaneous gland - calcium carbonate - chromic sulfate - cicuta virosa root - copper - folic acid - gold - cobalamin - iron - lachesis muta venom - melatonin - molybdenum - neurotrophin-3 - neurotrophin-4 - oxytocin - silicon dioxide - sus scrofa frontal lobe - sus scrofa temporal lobe - thyrotropin alfa - ubidecarenone - vanadium - zinc - brain-derived neurotrophic factor human -
Methylating Agent [EPC]
USES Temporary relief of symptoms related to: Difficulty concentrating Difficulty falling asleep Irritability
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.